4//SEC Filing
Belldegrun Arie 4
Accession 0001193125-25-204935
CIK 0001691082other
Filed
Sep 15, 8:00 PM ET
Accepted
Sep 16, 3:46 PM ET
Size
24.6 KB
Accession
0001193125-25-204935
Insider Transaction Report
Form 4
Vida Ventures GP III, L.L.C.
10% Owner
Transactions
- Conversion
Common Stock
2025-09-12+1,262→ 1,262 total(indirect: By Vida Ventures III-A, L.P.) - Conversion
Series C Preferred Stock
2025-09-12−13,302,666→ 0 total(indirect: By Vida Ventures III, L.P.)→ Common Stock (547,648 underlying) - Conversion
Series C Preferred Stock
2025-09-12−30,667→ 0 total(indirect: By Vida Ventures III-A, L.P.)→ Common Stock (1,262 underlying) - Conversion
Common Stock
2025-09-12+547,648→ 547,648 total(indirect: By Vida Ventures III, L.P.) - Purchase
Common Stock
2025-09-12$15.00/sh+332,566$4,988,490→ 880,214 total(indirect: By Vida Ventures III, L.P.) - Purchase
Common Stock
2025-09-12$15.00/sh+767$11,505→ 2,029 total(indirect: By Vida Ventures III-A, L.P.)
Holdings
- 1,434(indirect: By LLC)
Common Stock
Vida Ventures III, L.P.
10% Owner
Transactions
- Purchase
Common Stock
2025-09-12$15.00/sh+767$11,505→ 2,029 total(indirect: By Vida Ventures III-A, L.P.) - Conversion
Common Stock
2025-09-12+547,648→ 547,648 total(indirect: By Vida Ventures III, L.P.) - Conversion
Series C Preferred Stock
2025-09-12−13,302,666→ 0 total(indirect: By Vida Ventures III, L.P.)→ Common Stock (547,648 underlying) - Conversion
Series C Preferred Stock
2025-09-12−30,667→ 0 total(indirect: By Vida Ventures III-A, L.P.)→ Common Stock (1,262 underlying) - Conversion
Common Stock
2025-09-12+1,262→ 1,262 total(indirect: By Vida Ventures III-A, L.P.) - Purchase
Common Stock
2025-09-12$15.00/sh+332,566$4,988,490→ 880,214 total(indirect: By Vida Ventures III, L.P.)
Holdings
- 1,434(indirect: By LLC)
Common Stock
Vida Ventures III-A, L.P.
10% Owner
Transactions
- Purchase
Common Stock
2025-09-12$15.00/sh+767$11,505→ 2,029 total(indirect: By Vida Ventures III-A, L.P.) - Purchase
Common Stock
2025-09-12$15.00/sh+332,566$4,988,490→ 880,214 total(indirect: By Vida Ventures III, L.P.) - Conversion
Common Stock
2025-09-12+547,648→ 547,648 total(indirect: By Vida Ventures III, L.P.) - Conversion
Common Stock
2025-09-12+1,262→ 1,262 total(indirect: By Vida Ventures III-A, L.P.) - Conversion
Series C Preferred Stock
2025-09-12−13,302,666→ 0 total(indirect: By Vida Ventures III, L.P.)→ Common Stock (547,648 underlying) - Conversion
Series C Preferred Stock
2025-09-12−30,667→ 0 total(indirect: By Vida Ventures III-A, L.P.)→ Common Stock (1,262 underlying)
Holdings
- 1,434(indirect: By LLC)
Common Stock
Belldegrun Arie
10% Owner
Transactions
- Conversion
Common Stock
2025-09-12+547,648→ 547,648 total(indirect: By Vida Ventures III, L.P.) - Conversion
Series C Preferred Stock
2025-09-12−30,667→ 0 total(indirect: By Vida Ventures III-A, L.P.)→ Common Stock (1,262 underlying) - Purchase
Common Stock
2025-09-12$15.00/sh+767$11,505→ 2,029 total(indirect: By Vida Ventures III-A, L.P.) - Conversion
Common Stock
2025-09-12+1,262→ 1,262 total(indirect: By Vida Ventures III-A, L.P.) - Purchase
Common Stock
2025-09-12$15.00/sh+332,566$4,988,490→ 880,214 total(indirect: By Vida Ventures III, L.P.) - Conversion
Series C Preferred Stock
2025-09-12−13,302,666→ 0 total(indirect: By Vida Ventures III, L.P.)→ Common Stock (547,648 underlying)
Holdings
- 1,434(indirect: By LLC)
Common Stock
Vida Ventures Management Co. LLC
10% Owner
Transactions
- Conversion
Common Stock
2025-09-12+1,262→ 1,262 total(indirect: By Vida Ventures III-A, L.P.) - Purchase
Common Stock
2025-09-12$15.00/sh+332,566$4,988,490→ 880,214 total(indirect: By Vida Ventures III, L.P.) - Purchase
Common Stock
2025-09-12$15.00/sh+767$11,505→ 2,029 total(indirect: By Vida Ventures III-A, L.P.) - Conversion
Series C Preferred Stock
2025-09-12−13,302,666→ 0 total(indirect: By Vida Ventures III, L.P.)→ Common Stock (547,648 underlying) - Conversion
Common Stock
2025-09-12+547,648→ 547,648 total(indirect: By Vida Ventures III, L.P.) - Conversion
Series C Preferred Stock
2025-09-12−30,667→ 0 total(indirect: By Vida Ventures III-A, L.P.)→ Common Stock (1,262 underlying)
Holdings
- 1,434(indirect: By LLC)
Common Stock
Footnotes (5)
- [F1]Each share of Series C Preferred Stock has no expiration date and converted automatically into Common Stock immediately prior to the Issuer's initial public offering at a conversion ratio based upon the initial price per share to the public in the Issuer's initial public offering.
- [F2]These shares are held directly by Vida Ventures III, L.P. ("Vida III"). Vida Ventures GP III, L.L.C. ("Vida III GP") is the general partner of Vida III and may be deemed to have voting, investment, and dispositive power with respect to these securities. Arie Belldegrun, Helen Kim and Rajul Jain, are the members of the investment committee of Vida III GP (each, an "Investment Committee Member" and such committee, the "Investment Committee").
- [F3](Continued from Footnote 2) The Investment Committee and each of the Investment Committee Members may be deemed to share voting, investment and dispositive power with respect to these securities. Vida III GP, the Investment Committee and each of the Investment Committee Members disclaims beneficial ownership of the securities held of record by Vida III, and this report shall not be deemed an admission that they are the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their pecuniary interest therein, if any.
- [F4]These shares are held directly by Vida Ventures III-A, L.P. ("Vida III-A"). Vida III GP is the general partner of Vida III-A and may be deemed to have voting, investment, and dispositive power with respect to these securities. The Investment Committee and each of the Investment Committee Members may be deemed to share voting, investment and dispositive power with respect to these securities. Vida III GP, the Investment Committee and each of the Investment Committee Members disclaims beneficial ownership of the securities held of record by Vida III-A, and this report shall not be deemed an admission that they are the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their pecuniary interest therein, if any.
- [F5]These shares are held directly by Vida Ventures Management Co., LLC ("Vida Management"). Each Investment Committee Member (as defined below) disclaims beneficial ownership of the securities held of record by Vida Management, and this report shall not be deemed an admission that they are the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their pecuniary interest therein, if any.
Documents
Issuer
LB PHARMACEUTICALS INC
CIK 0001691082
Entity typeother
Related Parties
1- filerCIK 0001296549
Filing Metadata
- Form type
- 4
- Filed
- Sep 15, 8:00 PM ET
- Accepted
- Sep 16, 3:46 PM ET
- Size
- 24.6 KB